The latest announcement follows the recent US Food and Drug Administration (FDA) acceptance of the company’s new drug ...

Gilead Sciences has announced that the US Food and Drug Administration (FDA) has accepted its New Drug Application ...

US antivirals giant Gilead Sciences recently announced that the US Food and Drug Administration (FDA) has accepted its New ...

Gilead (GILD) announced that the European Medicines Agency has validated for parallel accelerated review the company’s marketing authorization ...

The EMA validation follows the announcement last week that the U.S. Food and Drug and Administration (FDA) accepted Gilead’s New Drug Applications (NDAs) for lenacapavir for PrEP and will assess ...

Foster City, California Tuesday, February 25, 2025, 16:00 Hrs [IST] ...

A groundbreaking injectable designed to curb the global spread of HIV is now at risk of being delayed due to Donald Trump's ...

It was a busy week for the biotech sector. While the fourth-quarter earnings season is nearing the end, other pipeline and ...

得益于抗逆转录病毒疗法的发展，HIV感染已经从致命疾病转变为可控的慢性病，患者只要每日坚持服药，就可获得与正常人相当的寿命。然而根据世界卫生组织（WHO）的统计，仅在2023年，全球仍有近4000万艾滋病患者，其中有130万新增感染，约63万人死于艾 ...

Foster City, California Thursday, February 20, 2025, 12:00 Hrs [IST] ...

Lenacapavir, a twice yearly injection that prevents HIV transmission, was named the breakthrough medicine of 2024. But without US foreign aid dollars, its delivery to millions worldwide is under ...